- Home
- ESTA vs CINGW Comparison
ESTA vs CINGW Comparison
Compare ESTA & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESTA
- CINGW
- Stock Information
- Founded
- ESTA 2004
- CINGW N/A
- Country
- ESTA Costa Rica
- CINGW United States
- Employees
- ESTA N/A
- CINGW 13
- Industry
- ESTA Industrial Specialties
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- ESTA Health Care
- CINGW Health Care
- Exchange
- ESTA Nasdaq
- CINGW Nasdaq
- Market Cap
- ESTA 877.1M
- CINGW N/A
- IPO Year
- ESTA 2018
- CINGW 2021
- Fundamental
- Price
- ESTA $34.10
- CINGW $0.03
- Analyst Decision
- ESTA Buy
- CINGW
- Analyst Count
- ESTA 7
- CINGW 0
- Target Price
- ESTA $59.17
- CINGW N/A
- AVG Volume (30 Days)
- ESTA 575.4K
- CINGW N/A
- Earning Date
- ESTA 05-07-2025
- CINGW N/A
- Dividend Yield
- ESTA N/A
- CINGW N/A
- EPS Growth
- ESTA N/A
- CINGW N/A
- EPS
- ESTA N/A
- CINGW N/A
- Revenue
- ESTA $170,235,000.00
- CINGW N/A
- Revenue This Year
- ESTA $27.13
- CINGW N/A
- Revenue Next Year
- ESTA $24.82
- CINGW N/A
- P/E Ratio
- ESTA N/A
- CINGW N/A
- Revenue Growth
- ESTA 9.27
- CINGW N/A
- 52 Week Low
- ESTA $26.56
- CINGW N/A
- 52 Week High
- ESTA $60.12
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- ESTA 58.16
- CINGW N/A
- Support Level
- ESTA $32.25
- CINGW N/A
- Resistance Level
- ESTA $36.86
- CINGW N/A
- Average True Range (ATR)
- ESTA 1.63
- CINGW 0.00
- MACD
- ESTA 0.82
- CINGW 0.00
- Stochastic Oscillator
- ESTA 81.56
- CINGW 0.00
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.